5/29
07:00 am
enta
Enanta Pharmaceuticals to Participate at the Jefferies Global Healthcare Conference
Low
Report
Enanta Pharmaceuticals to Participate at the Jefferies Global Healthcare Conference
5/27
03:15 am
enta
Antibiotic Resistance Markets Therapeutics, by Pathogen and Therapy Type to 2027: Search for Alternatives to Antibiotics Creates New Global Goldrush [Yahoo! Finance]
Low
Report
Antibiotic Resistance Markets Therapeutics, by Pathogen and Therapy Type to 2027: Search for Alternatives to Antibiotics Creates New Global Goldrush [Yahoo! Finance]
5/9
12:33 am
enta
Enanta Pharmaceuticals, Inc. (NASDAQ: ENTA) was upgraded by analysts at StockNews.com from a "sell" rating to a "hold" rating.
Low
Report
Enanta Pharmaceuticals, Inc. (NASDAQ: ENTA) was upgraded by analysts at StockNews.com from a "sell" rating to a "hold" rating.
5/8
08:05 am
enta
Enanta Pharmaceuticals Second Quarter 2024 Earnings: Revenues Beat Expectations, EPS Lags [Yahoo! Finance]
Low
Report
Enanta Pharmaceuticals Second Quarter 2024 Earnings: Revenues Beat Expectations, EPS Lags [Yahoo! Finance]
5/7
02:23 pm
enta
Enanta Pharmaceuticals, Inc. (NASDAQ: ENTA) had its price target lowered by analysts at HC Wainwright from $28.00 to $27.00. They now have a "buy" rating on the stock.
Low
Report
Enanta Pharmaceuticals, Inc. (NASDAQ: ENTA) had its price target lowered by analysts at HC Wainwright from $28.00 to $27.00. They now have a "buy" rating on the stock.
5/7
12:13 pm
enta
Enanta Pharmaceuticals, Inc. (NASDAQ: ENTA) had its price target lowered by analysts at JMP Securities from $23.00 to $22.00. They now have a "market outperform" rating on the stock.
Medium
Report
Enanta Pharmaceuticals, Inc. (NASDAQ: ENTA) had its price target lowered by analysts at JMP Securities from $23.00 to $22.00. They now have a "market outperform" rating on the stock.
5/7
10:38 am
enta
Enanta Pharmaceuticals, Inc. (NASDAQ:ENTA) Q2 2024 Earnings Call Transcript [Yahoo! Finance]
Neutral
Report
Enanta Pharmaceuticals, Inc. (NASDAQ:ENTA) Q2 2024 Earnings Call Transcript [Yahoo! Finance]
5/7
07:00 am
enta
Enanta Pharmaceuticals to Participate at the JMP Securities Life Sciences Conference
High
Report
Enanta Pharmaceuticals to Participate at the JMP Securities Life Sciences Conference
5/6
06:56 pm
enta
Enanta Pharmaceuticals (ENTA) Reports Q2 Loss, Tops Revenue Estimates [Yahoo! Finance]
High
Report
Enanta Pharmaceuticals (ENTA) Reports Q2 Loss, Tops Revenue Estimates [Yahoo! Finance]
5/6
04:10 pm
enta
Enanta Pharmaceuticals Reports Financial Results for its Fiscal Second Quarter with Webcast and Conference Call Today at 4:30 p.m. ET [Yahoo! Finance]
High
Report
Enanta Pharmaceuticals Reports Financial Results for its Fiscal Second Quarter with Webcast and Conference Call Today at 4:30 p.m. ET [Yahoo! Finance]
5/6
04:01 pm
enta
Enanta Pharmaceuticals Reports Financial Results for its Fiscal Second Quarter with Webcast and Conference Call Today at 4:30 p.m. ET
High
Report
Enanta Pharmaceuticals Reports Financial Results for its Fiscal Second Quarter with Webcast and Conference Call Today at 4:30 p.m. ET
5/3
08:44 am
enta
Strong week for Enanta Pharmaceuticals (NASDAQ:ENTA) shareholders doesn't alleviate pain of five-year loss [Yahoo! Finance]
Medium
Report
Strong week for Enanta Pharmaceuticals (NASDAQ:ENTA) shareholders doesn't alleviate pain of five-year loss [Yahoo! Finance]
4/30
07:22 am
enta
Enanta Pharmaceuticals Announces the Appointment of Matthew P. Kowalsky as Chief Legal Officer [Yahoo! Finance]
Medium
Report
Enanta Pharmaceuticals Announces the Appointment of Matthew P. Kowalsky as Chief Legal Officer [Yahoo! Finance]
4/30
07:10 am
enta
Enanta Pharmaceuticals Announces Inducement Grants Under Nasdaq Listing Rule 5635(c)(4)
Medium
Report
Enanta Pharmaceuticals Announces Inducement Grants Under Nasdaq Listing Rule 5635(c)(4)
4/30
07:00 am
enta
Enanta Pharmaceuticals Announces the Appointment of Matthew P. Kowalsky as Chief Legal Officer
Medium
Report
Enanta Pharmaceuticals Announces the Appointment of Matthew P. Kowalsky as Chief Legal Officer
4/29
07:13 am
enta
Enanta Pharmaceuticals to Host Conference Call on May 6 at 4:30 p.m. ET to Discuss its Financial Results for its Fiscal Second Quarter Ended March 31, 2024 [Yahoo! Finance]
Medium
Report
Enanta Pharmaceuticals to Host Conference Call on May 6 at 4:30 p.m. ET to Discuss its Financial Results for its Fiscal Second Quarter Ended March 31, 2024 [Yahoo! Finance]
4/29
07:00 am
enta
Enanta Pharmaceuticals to Host Conference Call on May 6 at 4:30 p.m. ET to Discuss its Financial Results for its Fiscal Second Quarter Ended March 31, 2024
Medium
Report
Enanta Pharmaceuticals to Host Conference Call on May 6 at 4:30 p.m. ET to Discuss its Financial Results for its Fiscal Second Quarter Ended March 31, 2024
4/22
04:22 pm
enta
ArriVent Appoints Kristine Peterson to its Board of Directors [Yahoo! Finance]
Low
Report
ArriVent Appoints Kristine Peterson to its Board of Directors [Yahoo! Finance]
4/17
07:12 am
enta
Enanta Pharmaceuticals Announces Data Presentation at ESCMID Global 2024 [Yahoo! Finance]
Medium
Report
Enanta Pharmaceuticals Announces Data Presentation at ESCMID Global 2024 [Yahoo! Finance]
4/17
07:00 am
enta
Enanta Pharmaceuticals Announces Data Presentation at ESCMID Global 2024
Medium
Report
Enanta Pharmaceuticals Announces Data Presentation at ESCMID Global 2024
4/6
02:04 am
enta
Enanta Pharmaceuticals, Inc. (NASDAQ: ENTA) was downgraded by analysts at StockNews.com from a "hold" rating to a "sell" rating.
Low
Report
Enanta Pharmaceuticals, Inc. (NASDAQ: ENTA) was downgraded by analysts at StockNews.com from a "hold" rating to a "sell" rating.
3/29
11:08 pm
enta
Enanta Pharmaceuticals, Inc. (NASDAQ: ENTA) was upgraded by analysts at StockNews.com from a "sell" rating to a "hold" rating.
Low
Report
Enanta Pharmaceuticals, Inc. (NASDAQ: ENTA) was upgraded by analysts at StockNews.com from a "sell" rating to a "hold" rating.
3/6
07:00 am
enta
Enanta Pharmaceuticals to Participate at Leerink Partners Global Biopharma Conference
Medium
Report
Enanta Pharmaceuticals to Participate at Leerink Partners Global Biopharma Conference